A Split-organ Delineation Approach for Dose Optimisation for Intensity-modulated Radiotherapy for Advanced T-stage Nasopharyngeal Carcinoma

Clinical Oncology

Volumn 20, Issue 2, 2008, Pages 134-141

  Chau, R M C ^a   Leung, S F ^a   Kam, M K M ^a   Cheung, K Y ^a   Kwan, W H ^a   Yu, K H ^a   Chiu, S K W ^a   Chan, A T C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Dose constraints; intensity modulated radiotherapy; nasopharyngeal carcinoma

Indexed keywords

ADVANCED CANCER; ARTICLE; BRAIN STEM; CANCER CONTROL; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COCHLEA; COCHLEAR NERVE; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NASOPHARYNX CARCINOMA; PAROTID GLAND; PATIENT CARE PLANNING; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION HAZARD; RISK ASSESSMENT; RISK REDUCTION; TEMPORAL LOBE;

BRAIN STEM; COCHLEA; COCHLEAR NERVE; HUMANS; NASOPHARYNGEAL NEOPLASMS; PAROTID GLAND; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TEMPORAL LOBE;

EID: 38849196764     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.10.006     Document Type: Article

References (21)

1. Chao K.S., Low D.A., Perez C.A., and Purdy J.A. Intensity-modulated radiation therapy in head and neck cancers: the Mallinckrodt experience. Int J Cancer 90 2 (2000) 92-103
2. Xia P., Fu K.K., Wong G.W., Akazawa C., and Verhey L.J. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48 2 (2000) 329-337
3. Sultanem K., Shu H.K., Xia P., et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 48 3 (2000) 711-722
4. Hunt M.A., Zelefsky M.J., Wolden S., et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 49 3 (2001) 623-632
5. Eisbruch A. Clinical aspects of IMRT for head-and-neck cancer. Med Dosim 27 2 (2002) 99-104
6. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 1 (2002) 12-22
7. Kam M.K., Teo P.M., Chau R.M., et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60 5 (2004) 1440-1450
8. Garden A.S., Morrison W.H., Rosenthal D.I., Chao K.S., and Ang K.K. Target coverage for head and neck cancers treated with IMRT: review of clinical experiences. Semin Radiat Oncol 14 2 (2004) 103-109
9. Porceddu S., Hope G., Wills J., et al. Intensity-modulated radiotherapy: examples of its utility in head and neck cancer. Australas Radiol 48 1 (2004) 51-57
10. Kwong D.L., Pow E.H., Sham J.S., et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 101 7 (2004) 1584-1593
11. Yao M., Dornfeld K.J., Buatti J.M., et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma - the University of Iowa experience. Int J Radiat Oncol Biol Phys 63 2 (2005) 410-421
12. Wolden S.L., Chen W.C., Pfister D.G., Kraus D.H., Berry S.L., and Zelefsky M.J. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64 1 (2006) 57-62
13. Baltas D., Kolotas C., Geramani K., et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 40 2 (1998) 515-524
14. Sanchez-Nieto B., and Nahum A.E. The delta-TCP concept: a clinically useful measure of tumour control probability. Int J Radiat Oncol Biol Phys 44 2 (1999) 369-380
15. Lyman J.T., and Wolbarst A.B. Optimization of radiation therapy, III: a method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13 1 (1987) 103-109
16. Eisbruch A., Ten Haken R.K., Kim H.M., Marsh L.H., and Ship J.A. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 3 (1999) 577-587
17. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49 4 (2001) 907-916
18. Blanco A.I., Chao K.S., El Naqa I., et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys 62 4 (2005) 1055-1069
19. Hunt M.A., Jackson A., Narayana A., and Lee N. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Int J Radiat Oncol Biol Phys 66 1 (2006) 296-304
20. Xia P., Lee N., Liu Y.M., et al. A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system. Int J Radiat Oncol Biol Phys 59 3 (2004) 886-896
21. Reinstein L.E., Wang X.H., Burman C.M., et al. A feasibility study of automated inverse treatment planning for cancer of the prostate. Int J Radiat Oncol Biol Phys 40 1 (1998) 207-214